NEOS Investment Management LLC Purchases 4,684 Shares of CME Group Inc. $CME

NEOS Investment Management LLC boosted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 8.7% in the second quarter, HoldingsChannel reports. The institutional investor owned 58,567 shares of the financial services provider’s stock after purchasing an additional 4,684 shares during the quarter. NEOS Investment Management LLC’s holdings in CME Group were worth $12,933,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. AXQ Capital LP purchased a new position in shares of CME Group in the second quarter valued at about $3,390,000. Waycross Investment Management Co purchased a new stake in shares of CME Group during the second quarter worth about $1,034,000. Nykredit A S purchased a new stake in shares of CME Group during the second quarter worth about $34,092,000. B. Metzler seel. Sohn & Co. AG raised its stake in CME Group by 69.4% during the 2nd quarter. B. Metzler seel. Sohn & Co. AG now owns 35,192 shares of the financial services provider’s stock valued at $7,771,000 after purchasing an additional 14,418 shares during the period. Finally, PYA Waltman Capital LLC bought a new stake in CME Group during the 2nd quarter valued at approximately $2,571,000. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, Director William Shepard purchased 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The shares were bought at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on CME shares. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Bank of America lifted their price objective on shares of CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research report on Thursday, July 23rd. TD Cowen reissued a “buy” rating and issued a $292.00 target price on shares of CME Group in a report on Thursday. Erste Group Bank lowered shares of CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Finally, UBS Group cut their target price on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $289.75.

View Our Latest Stock Analysis on CME

CME Group Price Performance

Shares of CME Group stock opened at $281.29 on Friday. The stock has a 50 day moving average of $258.76 and a 200 day moving average of $278.38. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The firm has a market cap of $101.15 billion, a PE ratio of 23.86, a PEG ratio of 3.32 and a beta of 0.24. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter last year, the business posted $2.96 EPS. The firm’s revenue for the quarter was up .8% compared to the same quarter last year. On average, research analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 44.11%.

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.